Home > Quotes > IBB

iShares NASDAQ Biotechnology Index Fund Stock Quote & Summary Data

(ETF)
IBB 
$180.09
*  
1.92
  negative  
1.05%
Get IBB Alerts
*Delayed - data as of May 20, 2013 14:40 ET 
Exchange: NASDAQ

Community Rating:
View:    IBB Real Time
 
 

Symbol List Views

ETF Details

CHARTS

ETF NEWS

FUNDAMENTALS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 | Sponsored

Best Bid /Ask: $ 180.03 / $ 180.07
1 Year Target:
Today's High/Low:  / 
Share Volume:
50 Day Avg. Daily Volume This is the average share volume for the past 50 trading days, for NASDAQ stocks and 90 trading days for Non-NASDAQ stocks. This field allows you to compare today’s trading to the average daily volume. N/A
Previous Close: $ 182.01
52 Week High /Low: $ 186.98 / $ 114.97
Market cap “Market Capitalization” is a measure of the estimated value of the common equity securities of the company or their equivalent. It does not include securities convertible into the common equity securities. “Market Capitalization” is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). NASDAQ does not use this value to determine compliance with the listing requirements. 3,250,624,500
Annualized dividend $ 0.4124
Ex Dividend Date Dec. 19, 2012
Dividend Payment Date Dec. 26, 2012
Current Yield 0.23 %
NASDAQ Official Open Price NASDAQ Official Opening Price: This process identifies the NASDAQ-specific opening prices for NASDAQ-listed issues. $ 182.33
Date of Open Price This field refers to the date the NASDAQ Official Open Price was disseminated for a given stock. It is possible that the date will not be from the current trading day; this indicates that the stock didn't trade on NASDAQ during the current trading day. The NASDAQ Official Open Price is updated only when the stock is traded on NASDAQ. May 20, 2013
NASDAQ Official Close Price The NASDAQ® Official Closing Price (NOCP) is a process for identifying the NASDAQ market-specific closing price for NASDAQ-listed issues. The NOCP replaces the NASDAQ market-specific closing price that was based solely on the last reported NASDAQ trade. Subject to review by NASDAQ MarketWatch, the NOCP will equal the normalized price of the last trade reported to NASDAQ’s proprietary trade reporting system—Automated Confirmation Transaction ServiceSM (ACTSM—with a last sale eligible sale condition modifier as of 4:00:02 p.m., US Eastern Time. "Normalizing" the NOCP means it will be adjusted to the nearest prevailing inside quote whenever the last sale is reported away from the inside market. Market participants, data distributors and investors will be provided with the NOCP for all NASDAQ Global Select MarketSM, NASDAQ Global MarketSM and NASDAQ Capital MarketSM securities. $ 182.01
Date of Close Price This field refers to the date the NOCP was disseminated for a given stock. It is possible that the date will not be from the prior day; this indicates that the stock didn't trade on NASDAQ on the prior day. The NOCP is updated only when the stock is traded on NASDAQ. May 17, 2013
Community Sentiment

 Intraday Chart

5d | 1m | 6m | 12m | More Charting



Description:The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the NASDAQ Biotechnology Index (the "Underlying Index"). The Underlying Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals which also meet other eligibility criteria determined by NASDAQ, including minimum market capitalization and liquidity requirements. The Fund generally invests at least 90% of its assets in securities of the Underlying Index and in depositary receipts representing securities of the Underlying Index.

Underlying Index NASDAQ Biotechnology Index
Management Fee 0.48
Asset Class Equity
Leverage 1


News Headlines for IBB

Biotechnology ETF Investing 101 - ETF News And Commentary
5/20/2013 11:03:46 AM - Zacks.com
ACADIA Pharmaceuticals Added to NASDAQ Biotechnology Index
5/20/2013 9:00:00 AM - Business Wire
Hyperion Therapeutics Added to NASDAQ Biotechnology Index (NBI)
5/16/2013 4:05:00 PM - GlobeNewswire
NewLink Genetics to Be Added to NASDAQ Biotechnology Index
5/16/2013 8:10:00 AM - Market Wire
Oil Pulling Back, Gold Retesting Lows: What 8 Key Charts Are Signaling
5/15/2013 11:35:00 AM - Minyanville
Top Holdings
REGN Regeneron Pharmaceuticals 9.17%
GILD Gilead Sciences 8.51%
AMGN Amgen Inc. 8.26%
CELG Celgene Corp. 7.17%
ALXN Alexion Pharmaceuticals 6.62%
BIIB Biogen Idec Inc 5.86%
VRTX Vertex Pharmaceuticals Inc. 3.7%
PRGO Perrigo Company 3.57%
BMRN Biomarin Pharmaceutical Inc. 3.19%
MYL Mylan Inc. 3.03%
ONXX Onyx Pharmaceuticals 3.03%